Skip to main content
. 2014 Jan 1;28(1):112–116. doi: 10.1089/end.2013.0298

Table 3.

Procedure Details and Follow-Up Data

Procedure Technique Surgery Time (minutes) EBL (mL) # lesions removed Smallest lesion (cm) Largest lesion (cm) Pathology Periop steroid needed Postop steroid needed Follow-up time (months) Steroid use at follow-up Recurrence follow-up
1
Robotic
141
50
3
0.8
0.8
Pheochromocytoma
N
N
1.4
N
Y
2
Robotic
162
50
2
1.5
2.5
Pheochromocytoma
N
N
2.9
N
N
3
Robotic
285
300
4
1
2
Pheochromocytoma
Y
Y
20.3
Y
N
4
Robot
NR
NR
2
0.7
1.7
Pheochromocytoma
N
N
12.2
N
N
5
Laparoscopic
110
50
2
2
5
Hyperplasia
NR
NR
4.6
N
N
6
Laparoscopic
220
150
2
1
1.6
Pheochromocytoma
NR
N
14.8
N
N
7a
Robot
357
150
2
0.7
0.9
Pheochromocytoma
N
N
28.8
N
Y
8a
Robot
185
50
2
1.2
3.5
Pheochromocytoma
N
N
15.7
N
N
9b
Laparoscopic
NR
NR
4
1.5
2.5
Pheochromocytoma
N
N
1.2
N
N
10b Laparoscopic 200 200 3 1.5 2.8 Pheochromocytoma N N 1.2 N N
a

7 and 8 were staged bilateral procedures on the same patient.

b

Procedure 9 and 10 were synchronous bilateral procedures on the same patient.

NR=data not available; N=no; Y=yes.